首页> 外文OA文献 >POS-457 EFFICACY AND SAFETY OF RITUXIMAB VERSUS TACROLIMUS IN FREQUENTLY RELAPSING NEPHROTIC SYNDROME: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL

【2h】

POS-457 EFFICACY AND SAFETY OF RITUXIMAB VERSUS TACROLIMUS IN FREQUENTLY RELAPSING NEPHROTIC SYNDROME: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL

机译：Rituximab与Tacrolimus经常复发肾病综合征的POS-457疗效和安全性：一个开放标签随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
G. Mathew; A. Sinha; N. Grewal; A. Ahmad; P. Hari; A. Bagga;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献

1. EFFICACY AND SAFETY OF RITUXIMAB VERSUS TACROLIMUS IN FREQUENTLY RELAPSING NEPHROTIC SYNDROME: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL [J] . G. Mathew, A. Sinha, N. Grewal, Kidney International Reports . 2021,第4期

机译：Rituximab与Tacrolimus经常复发肾病综合征的疗效和安全性：开放标签随机对照试验
2. EFFICACY AND SAFETY OF PREDNISOLONE ON ALTERNATE DAYS MADE DAILY WITH INFECTIONS VERSUS LEVAMISOLE IN FREQUENTLY RELAPSING NEPHROTIC SYNDROME: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL [J] . A. Sinha, K. Ghanapriya, P. Hari, Kidney International Reports . 2021,第4期

机译：泼尼松龙在每日感染的交替日对百分子患者的交替日对肾病综合征的疗效和安全性：开放标签随机对照试验
3. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial [J] . Yadav Menka, Sinha Aditi, Khandelwal Priyanka, Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2019,第5期

机译：低剂量日常与交替日泼尼松龙经常复发肾病综合征的疗效：开放式随机对照试验
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial [O] . Julien Hogan, Aubriana Perez, Anne-Laure Sellier-Leclerc, 2020

机译：静脉内免疫球蛋白与利妥昔单抗与rituximab在儿童发病类固醇依赖性和经常复发性肾病综合征的疗效和安全性：多期一组随机对照试验的方案
7. Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial [O] . Julien Hogan, Aubriana Perez, Anne-Laure Sellier-Leclerc, 2020

机译：静脉内免疫球蛋白与利妥昔单抗与rituximab在儿童发病类固醇依赖性和经常复发性肾病综合征的疗效和安全性：多期一组随机对照试验的方案

POS-457 EFFICACY AND SAFETY OF RITUXIMAB VERSUS TACROLIMUS IN FREQUENTLY RELAPSING NEPHROTIC SYNDROME: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL

著录项

引文网络

相似文献

相关主题

期刊订阅